MAFTIVIMAB

· Regeneron Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MAFTIVIMAB, covering 2020-10-14 to 2020-10-14. Get the full timeline:

Most recent: FDA Approved: INMAZEB — Original Application (Regeneron Pharmaceuticals, Inc.)